Australia markets close in 4 hours 42 minutes
  • ALL ORDS

    6,844.70
    +72.70 (+1.07%)
     
  • ASX 200

    6,633.50
    +71.90 (+1.10%)
     
  • AUD/USD

    0.7299
    +0.0012 (+0.16%)
     
  • OIL

    43.06
    0.00 (0.00%)
     
  • GOLD

    1,828.90
    -8.90 (-0.48%)
     
  • BTC-AUD

    25,068.51
    -43.20 (-0.17%)
     
  • CMC Crypto 200

    365.78
    +4.35 (+1.20%)
     
  • AUD/EUR

    0.6161
    +0.0009 (+0.15%)
     
  • AUD/NZD

    1.0530
    +0.0004 (+0.04%)
     
  • NZX 50

    12,551.00
    +49.26 (+0.39%)
     
  • NASDAQ

    11,905.94
    -0.50 (-0.00%)
     
  • FTSE

    6,333.84
    -17.61 (-0.28%)
     
  • Dow Jones

    29,591.27
    +327.79 (+1.12%)
     
  • DAX

    13,126.97
    -10.28 (-0.08%)
     
  • Hang Seng

    26,486.20
    +34.66 (+0.13%)
     
  • NIKKEI 225

    25,527.37
    0.00 (0.00%)
     

Asian Stocks Up Despite COVID-19 Uncertainty

·2-min read

By Gina Lee

Investing.com – Asian stock markets were up on Tuesday with modest gains despite the economic uncertainty unleashed by the COVID-19 pandemic.

Japan’s Nikkei 225 rose 1.89% by 10:23 PM ET (3:23 AM GMT). Conglomerate Softbank Group (T:9984) saw its shares gain 2.95% as they rallied from an earlier drop of more than 3% the day before. The company announced that its Vision Fund expected to see a loss of JPY 1.8 trillion ($16.69 billion) for the 2019 fiscal year due to a “deteriorating market environment.”

China’s Shanghai Composite was up 0.57% while the Shenzhen Component was up 0.93%. with Chinese trade data for March set to be released later in the day.

Investors will be taking a close look at the data as Wuhan lifted its three-month lockdown in the previous week.

South Korea’s KOSPI gained 1.6% as the country prepares to vote for its National Assembly representatives on Wednesday.

The S&P/ASX 200 rose 0.49% and Hong Kong’s Hang Seng Index was up by 0.4% as investors resumed work from the four-day Easter weekend.

But some investors are skeptical as companies enter into a difficult earnings seasons and governments assess the pandemic’s economic damage as the search for a cure continues.

“Companies, analysts, traders, investors and strategists to some extent are ‘flying into earnings season without instruments,’” John Stoltzfus, chief investment strategist at Oppenheimer&Co., told Bloomberg. “The unprecedented nature of the economic shutdown, social distancing and sheltering in place ordered by officials provides an overhang of uncertainty.”

Related Articles

Disney enters $5 billion credit agreement

Exxon raises $9.5 billion to load up on cash while debt market still open to new deals

Asia shares jump but pandemic hangs heavy over outlook